Skip to content
OpenCapital
Get started

Comp X International CIX Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By segment

See full
Security Products26%+23.8%

Other financials

Income statement

See full
Revenue$40.6M+0.7%
Gross profit$13.3M+9.0%
Operating income$7.1M+20.1%
Net income$5.9M+14.1%
EPS (diluted)$0.48+14.3%

Balance sheet

See full
Cash & equivalents$49.4M-11.9%
Total debt$1.0M—
Total equity$140.8M-4.6%
Total assets$156.4M-3.6%

Cash flow

See full
Operating cash flow-$1.2M-745%
CapEx$404.0K-50.9%
Free cash flow-$1.6M-62.8%

Valuation

See full
Market cap$335.06M+13.5%
Enterprise value$286.64M—
P/E16.6×+0.2×
P/S2.1×+0.1×

Profitability

See full
Gross margin31.1%+1.5pp
Operating margin15%+2.1pp
Net margin12.7%+0.6pp
FCF margin11.7%-1.3pp

Returns & leverage

See full
Return on equity14%+2.7pp
Debt / equity0×—
Current ratio7×-0.7×